by John Conrad | Jun 14, 2024 | iBIO News
From John: The news coverage of the BioPharma industry has been a study in contrasts. As I compile the daily NewsBrief, I come across numerous articles highlighting companies, both large and small, that are compelled to reduce their workforce due to insufficient...
by John Conrad | Jun 13, 2024 | NewsBrief
Meitheal Pharmaceuticals, a Chicago-based pharmaceutical company, has been named the second fastest growing company on Crain’s Fast 50 list. The company recorded an impressive 13,294.6% growth rate, with over $230 million in revenue and a total of 90 employees,...
by John Conrad | Jun 6, 2024 | NewsBrief
The biopharma sector has undergone significant changes in venture funding and investment trends during the first quarter of 2024, according to a recent PitchBook report. Despite a decrease in deal count, the sector saw an increase in venture funding, with $7.4 billion...
by John Conrad | Jun 4, 2024 | NewsBrief
Formosa Laboratories, Inc., a leading API supplier and CDMO headquartered in Taiwan, has successfully completed its acquisition of SynChem, Inc., a contract research laboratory located in the suburbs of Chicago. The strategic move, finalized on June 3, 2024, aims to...
by John Conrad | May 6, 2024 | Member News
Xeris announced a collaboration and licensing agreement with Beta Bionics. The agreement involves developing and commercializing a glucagon product using Xeris’ XeriSol™ technology for Beta Bionics’ proprietary bi-hormonal pump system for diabetes...
